Zentalis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.About ZNTL
Zentalis Pharmaceuticals, Inc. is a clinical oncology innovator developing an oral, non-chemotherapy, biomarker-driven treatment approach for ovarian cancer and multiple tumor types. The therapeutics development and biomarker expertise is advancing monotherapy and combination studies of its investigational potential first-in-class WEE1 inhibitor, azenosertib.
ZNTL Key Statistics
Stock Snapshot
Zentalis Pharmaceuticals(ZNTL) stock is priced at $4.74, giving the company a market capitalization of 337.07M. It carries a P/E multiple of -2.73.
During the trading session on 2026-08-03, Zentalis Pharmaceuticals(ZNTL) shares reached a daily high of $4.98 and a low of $4.66. At a current price of $4.74, the stock is +1.7% higher than the low and still -4.7% under the high.
Trading volume for Zentalis Pharmaceuticals(ZNTL) stock has reached 940.65K, versus its average volume of 1.22M.
Over the past 52 weeks, Zentalis Pharmaceuticals(ZNTL) stock has traded between a high of $6.95 and a low of $1.21.
Over the past 52 weeks, Zentalis Pharmaceuticals(ZNTL) stock has traded between a high of $6.95 and a low of $1.21.
Analyst ratings
60%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.